Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women

Obesity

Volumn 19, Issue 1, 2011, Pages 49-53

  Bredella, Miriam A ^a   Torriani, Martin ^a   Ghomi, Reza Hosseini ^a   Thomas, Bijoy J ^a   Brick, Danielle J ^a   Gerweck, Anu V ^a   Rosen, Clifford J ^b   Klibanski, Anne ^a   Miller, Karen K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ABDOMINAL FAT; ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE MARROW; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HOMEOSTASIS; HUMAN; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; OSTEOBLAST; OSTEOPOROSIS; PATHOLOGY; PHYSIOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOGRAPHY; REGRESSION ANALYSIS; TRABECULAR BONE;

ADIPOSE TISSUE; ADIPOSITY; ADULT; BODY COMPOSITION; BONE DENSITY; BONE MARROW; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTRA-ABDOMINAL FAT; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 78650677721     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.106     Document Type: Article

References (31)

1. Rexrode KM, Carey VJ, Hennekens CH et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-1848.
2. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008;117:1658-1667.
3. Albala C, Yáñez M, Devoto E et al. Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes Relat Metab Disord 1996;20:1027-1032.
4. Reid IR, Plank LD, Evans MC. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 1992;75:779-782.
5. Gilsanz V, Chalfant J, Mo AO et al. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009;94:3387-3393.
6. von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E. Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int 2007;18:1337-1344. (Pubitemid 47389466)
7. Papakitsou E F, Margioris AN, Dretakis KE et al. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas 2004;47:185-193.
8. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006;2:35-43.
9. Takada I, Suzawa M, Matsumoto K, Kato S. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann N Y Acad Sci 2007;1116:182-195.
10. Rosen CJ. Bone remodeling, energy metabolism, and the molecular clock. Cell Metab 2008;7:7-10.
11. Vikman K, Isgaard J, Edén S. Growth hormone regulation of insulin-like growth factor-I mRNA in rat adipose tissue and isolated rat adipocytes. J Endocrinol 1991;131:139-145.
12. Bredella MA, Fazeli PK, Miller KK et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 2009;94:2129-2136.
13. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol 2001;22:1620-1627.
14. Schellinger D, Lin CS, Lim J et al. Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: their ratio as a new indicator of bone weakening. AJR Am J Roentgenol 2004;183:1761-1765.
15. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev 1998;19:55-79.
16. Gevers E F, Loveridge N, Robinson IC. Bone marrow adipocytes: a neglected target tissue for growth hormone. Endocrinology 2002;143:4065-4073.
17. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 2008;29:535-559.
18. Hwu CM, Kwok CF, Lai TY et al. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience. J Clin Endocrinol Metab 1997;82:3285-3292.
19. Makimura H, Stanley T, Mun D, You SM, Grinspoon S. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab 2008;93: 4254-4260.
20. Miller KK, Biller BM, Lipman JG et al. Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab 2005;90:768-774.
21. Pijl H, Langendonk JG, Burggraaf J et al. Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab 2001;86:5509-5515.
22. Bredella MA, Torriani M, Thomas BJ et al. Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J Clin Endocrinol Metab 2009;94:3995-4002.
23. Biller BM, Samuels MH, Zagar A et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002;87:2067-2079.
24. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
25. Borkan GA, Gerzof SG, Robbins AH et al. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982;36:172-177.
26. Klein KO, Larmore KA, de Lancey E et al. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 1998;83:3469-3475.
27. Shen W, Chen J, Punyanitya M et al. MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int 2007;18:641-647.
28. Justesen J, Stenderup K, Ebbesen EN et al. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001;2:165-171.
29. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-γ2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell 2004;3:379-389.
30. Mukherjee A, Murray RD, Shalet SM. Impact of growth hormone status on body composition and the skeleton. Horm Res 2004;62(Suppl 3):35-41.
31. Rosen CJ, Ackert-Bicknell CL, Adamo ML et al. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 2004;35:1046-1058.